Innate Pharma S.A. (OTCMKTS:IPHYF – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 6,000 shares, a growth of 22.4% from the September 15th total of 4,900 shares. Based on an average daily volume of 600 shares, the short-interest ratio is presently 10.0 days.
Innate Pharma Stock Performance
OTCMKTS IPHYF remained flat at $2.25 during trading on Tuesday. Innate Pharma has a 1 year low of $1.93 and a 1 year high of $2.90. The stock has a fifty day moving average of $2.22 and a two-hundred day moving average of $2.29.
About Innate Pharma
Further Reading
- Five stocks we like better than Innate Pharma
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What is a Special Dividend?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Innate Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innate Pharma and related companies with MarketBeat.com's FREE daily email newsletter.